These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2650069)

  • 21. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
    Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
    J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limb allotransplantation in rats: combined immunosuppression by FK-506 and 15-deoxyspergualin.
    Muramatsu K; Doi K; Kawai S
    J Hand Surg Am; 1999 May; 24(3):586-93. PubMed ID: 10357540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin transplantation in rats and monkeys: evaluation of efficient treatment with 15-deoxyspergualin.
    Dickneite G; Schorlemmer HU; Weinmann E; Bartlett RR; Sedlacek HH
    Transplant Proc; 1987 Oct; 19(5):4244-7. PubMed ID: 3314023
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of cyclosporin A in rat kidney grafts.
    Simms MH; Cruickshank JK; Blainey JD; Cameron AH; Barnes AD
    Transplant Proc; 1980 Jun; 12(2):256-60. PubMed ID: 6994293
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative efficacy of immunosuppressive drugs in xenografting.
    Thomas FT; DeMasi RJ; Araneda D; Marchman W; Alqaisi M; Larkin EW; Condie RM; Carobbi A; Thomas JM
    Transplant Proc; 1990 Jun; 22(3):1083-5. PubMed ID: 1693452
    [No Abstract]   [Full Text] [Related]  

  • 27. Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection.
    Herbort CP; Matsubara M; Nishi M; Mochizuki M
    Jpn J Ophthalmol; 1989; 33(2):212-20. PubMed ID: 2474684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical steroid, cyclosporin A, and the outcome of rat corneal allografts.
    Williams KA; Erickson SA; Coster DJ
    Br J Ophthalmol; 1987 Mar; 71(3):239-42. PubMed ID: 3548812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation.
    Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115
    [No Abstract]   [Full Text] [Related]  

  • 31. 15-Deoxyspergualin and primate heart transplantation.
    Kapelanski DP; Perelman MJ; Faber LA; Paez DE; Rose EF; Behrendt DM
    J Heart Transplant; 1990; 9(6):668-73; discussion 673-4. PubMed ID: 2277306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mode of action of immunosuppressive drugs evaluated with the aid of the immunostimulator LS-2616: studies on rejecting rat cardiac allografts.
    Wanders A; Gannedahl G; Gerdin B; Tufveson G
    Transplant Proc; 1992 Feb; 24(1):274-5. PubMed ID: 1539280
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylactic use of deoxyspergualin in living related renal transplantation.
    Okazaki H; Sato T; Jimbo M; Senga S; Amada N; Oguma S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1094-5. PubMed ID: 1989157
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.
    Wang J; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655
    [No Abstract]   [Full Text] [Related]  

  • 35. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.
    Yuh DD; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporin therapy for treatment of rat heart allograft rejection.
    Westra AL; Petersen AH; Prop J; Wildevuur CR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):963-4. PubMed ID: 2650301
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolongation of allogeneic transplanted skin grafts by A85 4777, a new immunosuppressive homopiperazine derivative.
    Schorlemmer H; Bartlett RR; Wolf E; Seiler FR
    Transplant Proc; 1990 Aug; 22(4):1671-3. PubMed ID: 2389431
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting.
    Hisanaga M; Nakajima Y; Yabuuchi H; Nakano H
    Transplant Proc; 1992 Jun; 24(3):1043-4. PubMed ID: 1376513
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppressive activities of 15-deoxyspergualin in animals.
    Nemoto K; Hayashi M; Abe F; Nakamura T; Ishizuka M; Umezawa H
    J Antibiot (Tokyo); 1987 Apr; 40(4):561-2. PubMed ID: 3294775
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
    Ueno M; Nakajima Y; Segawa M; Hisanaga M; Yabuuchi H; Yoshimura A; Nakano H
    Transplant Proc; 1992 Apr; 24(2):638-40. PubMed ID: 1373546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.